| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701723 | Journal of Thoracic Oncology | 2017 | 33 Pages |
Abstract
On the basis of the prognostic scoring model, the addition of IC to nCRT may provide a DFS benefit in high-risk patients with a risk score higher than 3.5. Prospective validation is warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mian MD, Zhongxing MD, Weiye MD, Cai MD, Ritsuko MD, Mariela MD, Wayne L. MD, Linus MD, PhD, Steven H. MD, PhD,